| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 156,500 | 124,473 | 107,406 | 113,549 | | Cost of Revenue |
-
|
-
| 25,037 | (9,194) | | | Gross Profit | 156,500 | 124,473 | 82,369 | 122,743 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,827 | 7,519 | (17,349) | 17,644 | | Non Recurring | 33,750 | 307,108 | 2,350,820 |
-
| | Others | 89,730 | 1,979 | 634,631 | 2,150 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,193 | (192,133) | (2,885,733) | 102,949 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (13,849) | 13,849 | 243,191 | (176,044) | | Earnings Before Interest And Taxes | 10,316 | (178,271) | (2,642,574) | (72,676) | | Interest Expense | 54,172 | 60,544 | 70,564 | 73,651 | | Income Before Tax | (43,856) | (238,815) | (2,713,138) | (146,327) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (43,856) | (238,815) | (2,713,138) | (146,327) | | | Non-recurring Events | | Discontinued Operations | (142) | (33) | (930) | 227 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (43,998) | (238,848) | (2,714,068) | (146,100) | | Preferred Stock And Other Adjustments | (3,376) | (3,375) | (3,375) | (3,375) | | | Net Income Applicable To Common Shares | ($47,374) | ($242,223) | ($2,717,443) | ($149,475) |
|
0.51% Nasdaq 
Income Statement
